COMPASS Pathways plc (CMPS): Insider Trading, Congress Trades & Research | Tormere

CMPS

$8.59+2.14%visit website

COMPASS Pathways plc

Market Cap

$1.2B

Live price × SEC shares (Oct 28, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

2.41

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

8.6

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Sep 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Research & development	29,906	26,480	29,175	23,458	109,019
Selling, general & administrative				32,979
Total operating expenses	45,952	42,904	52,372	56,437	197,665
Operating income	(45,952)	(42,904)	(52,372)	(56,437)	(197,665)
Interest expense	1,137	1,465	1,483	1,505	5,590
Pretax income	(96,612)	91,191	(253,463)	(10,937)	(269,821)
Income tax	(2,734)	(11)	331	(1,106)	(3,520)
Net income	(93,878)	91,202	(253,794)	(9,831)	(266,301)
EPS (basic) ($)		0.71	(1.88)	(0.07)	—
EPS (diluted) ($)		(0.30)	(1.88)	(0.31)	—
Weighted avg. shares (basic)		110,065	135,040	138,719
Weighted avg. shares (diluted)		130,267	135,040	162,568

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 3, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 21 more quarters, back to Jun 2020, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

No Form 4 transactions on record.

Recent News

How Investors May Respond To COMPASS Pathways (CMPS) Smaller Loss And FDA Progress

Yahoo · 2026-11-04

Compass Pathways: 3 Key Takeaways for Long-Term Investors

Yahoo · 2026-11-04

BIT Capital GmbH Adds 1.8 Million Compass Pathways (CMPS) Shares in $12.44 Trade

GuruFocus · 2026-11-04

Compass Pathways (CMPS) Q3 2026 Earnings Call Transcript

Yahoo · 2026-11-03

Sector Update: Healthcare Stocks Advance Tuesday Afternoon

Yahoo · 2026-11-03

Compass to submit psilocybin depression drug for approval imminently after stock wobbles

BioSpace · 2026-11-03

Compass Pathways Q3 Earnings Call Highlights

Yahoo · 2026-11-03

CMPS: COMP360 advances toward a potential 2027 launch, backed by $444 million in cash

TradingView · 2026-11-03

COMPASS Pathways stock rebounds after earnings (CMPS:NASDAQ)

Seeking Alpha · 2026-11-03

Compass Pathways To Complete COMP360 FDA Filing Within Two Weeks — CEO Nath Eyes Launch In First Half Of 2027

Yahoo · 2026-11-03

COMPASS Pathways plc (CMPS) Q3 2026 Earnings Call Transcript

SeekingAlpha · 2026-11-03

Compass Pathways (NASDAQ:CMPS) Narrows Q3 Loss as Final NDA Submission Nears

ChartMill · 2026-11-03

Earnings Flash (CMPS) Compass Pathways Posts Q3 Loss $0.31 a Share, Vs. FactSet Est of $0.39 Loss

Moomoo · 2026-11-03

Compass Pathways Announces Third Quarter 2026 Financial Results and Business Highlights

Yahoo · 2026-11-03

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga · 2026-11-03

Informational purposes only, not investment advice.